OMCL Key Statistics, Chart & Performance
The current stock price of OMCL is 50.74 USD. In the past month the price increased by 15.4%. In the past year, price increased by 20.01%.
OMCL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.23 | 218.96B | ||
| ISRG | INTUITIVE SURGICAL INC | 68.09 | 207.82B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.1 | 144.75B | ||
| SYK | STRYKER CORP | 27.91 | 140.55B | ||
| BDX | BECTON DICKINSON AND CO | 14.06 | 57.87B | ||
| IDXX | IDEXX LABORATORIES INC | 56.57 | 56.96B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.12 | 49.40B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 19.02 | 39.76B | ||
| RMD | RESMED INC | 25.5 | 36.85B | ||
| DXCM | DEXCOM INC | 36.24 | 26.29B | ||
| PODD | INSULET CORP | 63.25 | 20.33B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.48 | 18.40B |
Related stock screener links
About OMCL
Company Profile
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. The company is headquartered in Fort Worth, Texas and currently employs 3,600 full-time employees. The company went IPO on 2001-08-08. The firm is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
Company Info
OMNICELL INC
4220 North Freeway
Fort Worth TEXAS 94043 US
CEO: Randall A. Lipps
Employees: 3600
Phone: 18774159990
OMNICELL INC / OMCL FAQ
What does OMNICELL INC do?
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. The company is headquartered in Fort Worth, Texas and currently employs 3,600 full-time employees. The company went IPO on 2001-08-08. The firm is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
Can you provide the latest stock price for OMNICELL INC?
The current stock price of OMCL is 50.74 USD. The price increased by 0.3% in the last trading session.
Does OMCL stock pay dividends?
OMCL does not pay a dividend.
How is the ChartMill rating for OMNICELL INC?
OMCL has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Where is OMNICELL INC (OMCL) stock traded?
OMCL stock is listed on the Nasdaq exchange.
What is the Short Interest ratio of OMNICELL INC (OMCL) stock?
The outstanding short interest for OMNICELL INC (OMCL) is 6.22% of its float.
OMCL Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to OMCL. When comparing the yearly performance of all stocks, OMCL is one of the better performing stocks in the market, outperforming 91.57% of all stocks.
OMCL Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to OMCL. OMCL has an average financial health and profitability rating.
OMCL Financial Highlights
Over the last trailing twelve months OMCL reported a non-GAAP Earnings per Share(EPS) of 1.82. The EPS increased by 27.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.69% | ||
| ROA | 1.02% | ||
| ROE | 1.63% | ||
| Debt/Equity | 0.14 |
OMCL Forecast & Estimates
14 analysts have analysed OMCL and the average price target is 52.53 USD. This implies a price increase of 3.53% is expected in the next year compared to the current price of 50.74.
For the next year, analysts expect an EPS growth of 2.6% and a revenue growth 7.19% for OMCL